113 related articles for article (PubMed ID: 16645632)
41. AMPK couples p73 with p53 in cell fate decision.
Adamovich Y; Adler J; Meltser V; Reuven N; Shaul Y
Cell Death Differ; 2014 Sep; 21(9):1451-9. PubMed ID: 24874608
[TBL] [Abstract][Full Text] [Related]
42. P19 H-ras induces G1/S phase delay maintaining cells in a reversible quiescence state.
Camats M; Kokolo M; Heesom KJ; Ladomery M; Bach-Elias M
PLoS One; 2009 Dec; 4(12):e8513. PubMed ID: 20046837
[TBL] [Abstract][Full Text] [Related]
43. Ha-Ras sensitizes transformed mouse skin cells to Anisomycin-induced apoptosis.
Santibañez JF; Hurtado C
FEBS Lett; 2005 Nov; 579(28):6459-64. PubMed ID: 16288745
[TBL] [Abstract][Full Text] [Related]
44. In good times and bad: p73 in cancer.
Oswald C; Stiewe T
Cell Cycle; 2008 Jun; 7(12):1726-31. PubMed ID: 18583938
[TBL] [Abstract][Full Text] [Related]
45. Loss of p53 induces cell proliferation via Ras-independent activation of the Raf/Mek/Erk signaling pathway.
Drosten M; Sum EY; Lechuga CG; Simón-Carrasco L; Jacob HK; García-Medina R; Huang S; Beijersbergen RL; Bernards R; Barbacid M
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):15155-60. PubMed ID: 25288756
[TBL] [Abstract][Full Text] [Related]
46. [Different effects of several signal pathway after liver transplantation].
Li GX; Gong NQ; Ye QF; Guo H
Zhonghua Gan Zang Bing Za Zhi; 2003 Dec; 11(12):742-4. PubMed ID: 14697137
[TBL] [Abstract][Full Text] [Related]
47. Roles of PKC isoforms in the induction of apoptosis elicited by aberrant Ras.
Zhu T; Tsuji T; Chen C
Oncogene; 2010 Feb; 29(7):1050-61. PubMed ID: 19838205
[TBL] [Abstract][Full Text] [Related]
48. p53 Attenuates the oncogenic Ras-induced epithelial-mesenchymal transition in human mammary epithelial cells.
Zhang J; Lei Y; Gao X; Liang Q; Li L; Feng J; Hou P; Han L; Zhang Y; Huang B; Lu J
Biochem Biophys Res Commun; 2013 May; 434(3):606-13. PubMed ID: 23583409
[TBL] [Abstract][Full Text] [Related]
49. Dynamic characteristics of transient responses.
Ozaki Y; Sasagawa S; Kuroda S
J Biochem; 2005 Jun; 137(6):659-63. PubMed ID: 16002986
[TBL] [Abstract][Full Text] [Related]
50. Sensitization of human pancreatic cancer cells harboring mutated K-ras to apoptosis.
Shen L; Kim SH; Chen CY
PLoS One; 2012; 7(7):e40435. PubMed ID: 22848379
[TBL] [Abstract][Full Text] [Related]
51. Mitochondrial defects trigger proliferation of neighbouring cells via a senescence-associated secretory phenotype in Drosophila.
Nakamura M; Ohsawa S; Igaki T
Nat Commun; 2014 Oct; 5():5264. PubMed ID: 25345385
[TBL] [Abstract][Full Text] [Related]
52. RAS unplugged: negative feedback and oncogene-induced senescence.
Bardeesy N; Sharpless NE
Cancer Cell; 2006 Dec; 10(6):451-3. PubMed ID: 17157783
[TBL] [Abstract][Full Text] [Related]
53. Protein-protein interactions in the regulation of the extracellular signal-regulated kinase.
Chuderland D; Seger R
Mol Biotechnol; 2005 Jan; 29(1):57-74. PubMed ID: 15668520
[TBL] [Abstract][Full Text] [Related]
54. The ERK cascade: a prototype of MAPK signaling.
Rubinfeld H; Seger R
Mol Biotechnol; 2005 Oct; 31(2):151-74. PubMed ID: 16170216
[TBL] [Abstract][Full Text] [Related]
55. Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation.
Deschênes-Simard X; Gaumont-Leclerc MF; Bourdeau V; Lessard F; Moiseeva O; Forest V; Igelmann S; Mallette FA; Saba-El-Leil MK; Meloche S; Saad F; Mes-Masson AM; Ferbeyre G
Genes Dev; 2013 Apr; 27(8):900-15. PubMed ID: 23599344
[TBL] [Abstract][Full Text] [Related]
56. Ras-MAPK signaling in osteogenic differentiation: friend or foe?
Schindeler A; Little DG
J Bone Miner Res; 2006 Sep; 21(9):1331-8. PubMed ID: 16939391
[No Abstract] [Full Text] [Related]
57. Functional analysis and secondary expression profiling of candidate genes deregulated in conjunction with oncogenic Ras signaling.
Raudies O; Kuban RJ; Hamacher F; Klein-Hitpass L; Tchernitsa OI; Sers C; Herzel HP; Schäfer R
Adv Enzyme Regul; 2005; 45():63-84. PubMed ID: 16023704
[No Abstract] [Full Text] [Related]
58. YAP: at the crossroad between transformation and tumor suppression.
Bertini E; Oka T; Sudol M; Strano S; Blandino G
Cell Cycle; 2009 Jan; 8(1):49-57. PubMed ID: 19106601
[TBL] [Abstract][Full Text] [Related]
59. [P73 protein in carcinogenesis and response to anti-tumor therapy].
Vinogradskaia GR
Vopr Onkol; 2013; 59(2):34-40. PubMed ID: 23814847
[No Abstract] [Full Text] [Related]
60. FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence.
Krejci P; Prochazkova J; Smutny J; Chlebova K; Lin P; Aklian A; Bryja V; Kozubik A; Wilcox WR
Bone; 2010 Jul; 47(1):102-10. PubMed ID: 20362703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
